Medication info
Alendronate Sodium Trihydrate 70 mg Tablets

Alendronate Sodium Trihydrate 70 mg Tablets

Prescription medicationTabletOral
Ingredient · strength
Sodium Alendronate Trihydrate›91.37mg / 1 tablet
Manufacturer / importer
Korea Syntex Pharmaceutical Co., Ltd.
Appearance
White oval tablet
Packaging
4 tablets/PTP[(4 tablets/PTP packaging (AluAlu)x1)]
Approval status
Active

MFDS item code 201906584 · Approved 2019.09.20

Summary

Main use
Treatment of osteoporosis in postmenopausal women and men
Who takes it
Adults
Adult dose
○ Take 70 mg of alendronic acid once weekly in the morning with plenty of water, at least 30 minutes before consuming food, beverages, or other medications (see Precautions). ○ Other beverages or food, including mineral water and barley tea, and medications may reduce the absorption of this medicine (see Drug Interactions). Consuming food within 30 minutes after taking this medicine or at the same time may reduce its absorption into the body and diminish its effect. Take this medicine as soon as you get up in the morning, swallowing it with plenty of water (170 ∼ 230 mL) to help the medicine reach the stomach promptly and reduce the possibility of esophageal irritation. Do not lie down for at least 30 minutes after taking this medicine and until after your first food intake. Do not take this medicine at bedtime or before getting up in the morning. Failure to follow these instructions may increase the risk of esophageal adverse reactions (see Warnings and Precautions). Patients whose intake of calcium and vitamin D from food is insufficient should take supplements (see Precautions). ○ The optimal duration of treatment has not been established. The safety and efficacy of this medicine for the treatment of osteoporosis are based on 4 years of clinical data. The need for continued treatment should be reassessed regularly in all patients receiving bisphosphonates. Patients at low risk of fracture should be considered for discontinuation after 3 ∼ 5 years of treatment. Patients who discontinue treatment should be regularly reassessed for fracture risk. ○ If you forget to take a dose on the scheduled day, take 70 mg the next morning, then resume taking it on your originally scheduled day and continue taking it regularly once weekly thereafter. However, do not take 2 tablets on the same day.

Ingredients

Manufacturer
Korea Syntex Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of osteoporosis in postmenopausal women and men

  • Osteoporosis
View approved original text

This medication is used for the treatment of osteoporosis in postmenopausal women and men.

How to take

Adult dose

○ Take 70 mg of alendronic acid once weekly in the morning with plenty of water, at least 30 minutes before consuming food, beverages, or other medications (see Precautions). ○ Other beverages or food, including mineral water and barley tea, and medications may reduce the absorption of this medicine (see Drug Interactions). Consuming food within 30 minutes after taking this medicine or at the same time may reduce its absorption into the body and diminish its effect. Take this medicine as soon as you get up in the morning, swallowing it with plenty of water (170 ∼ 230 mL) to help the medicine reach the stomach promptly and reduce the possibility of esophageal irritation. Do not lie down for at least 30 minutes after taking this medicine and until after your first food intake. Do not take this medicine at bedtime or before getting up in the morning. Failure to follow these instructions may increase the risk of esophageal adverse reactions (see Warnings and Precautions). Patients whose intake of calcium and vitamin D from food is insufficient should take supplements (see Precautions). ○ The optimal duration of treatment has not been established. The safety and efficacy of this medicine for the treatment of osteoporosis are based on 4 years of clinical data. The need for continued treatment should be reassessed regularly in all patients receiving bisphosphonates. Patients at low risk of fracture should be considered for discontinuation after 3 ∼ 5 years of treatment. Patients who discontinue treatment should be regularly reassessed for fracture risk. ○ If you forget to take a dose on the scheduled day, take 70 mg the next morning, then resume taking it on your originally scheduled day and continue taking it regularly once weekly thereafter. However, do not take 2 tablets on the same day.

Precautions

This medication may irritate the gastric mucosa, so patients with upper gastrointestinal diseases such as gastritis, esophagitis, or esophageal ulcers should be cautious. It should be taken with a sufficient amount of water, and the patient should not lie down for at least 30 minutes after ingestion to reduce the risk of esophageal irritation. If symptoms such as pain or difficulty swallowing in the esophagus or heartburn occur, discontinue use immediately and consult a physician. Patients with diseases that slow esophageal transit, severe renal impairment, hypocalcemia, and pregnant or nursing women should not take this medication. The absorption of this medication may be interfered with if taken with calcium supplements or antacids, so they should be taken at different times. During treatment, it is advisable to ensure adequate intake of calcium and vitamin D, and consider taking supplements if necessary. This medication can rarely cause pain in bones, joints, or muscles, so if symptoms are severe, consult a physician. Rare side effects such as osteonecrosis of the jaw may occur, so patients requiring dental treatment should consult their physician beforehand. Long-term use may lead to low-energy fractures in certain bones, so it is important to consult a physician if persistent pain occurs. Safety for children and adolescents under 18 has not been established, so use should be avoided. Elderly patients can use it, but some elderly may be more sensitive to medications, so caution is needed. Overdose may lead to hypocalcemia, gastrointestinal disturbances, etc., so the prescribed dosage and directions must be strictly followed. Pregnant women should not take this as it may affect the fetus, and it is also advisable for nursing women to refrain from using this medication.

Side effects

esophagitis, esophageal ulcer, esophageal erosion, esophageal obstruction, esophageal perforation, bleeding, gastric ulcer, duodenal ulcer, abdominal pain, nausea, indigestion, constipation, diarrhea, flatulence, acid reflux, vomiting, dysphagia, abdominal distension, gastritis, musculoskeletal pain, muscle spasm, headache, dizziness, dysgeusia, rash, erythema, anastomotic ulcer, urticaria, angioedema, myalgia, fatigue, weakness, fever, symptoms of hypocalcemia, peripheral edema, oropharyngeal ulcer, osteonecrosis of the jaw, joint swelling, low-energy fractures of the femoral head and other bones, itching, hair loss, mucocutaneous syndrome, toxic epidermal necrolysis, uveitis, scleritis, episcleritis, cholesteatoma of the external auditory canal

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to air and moisture, so it should be kept in a tightly closed container. It is also advisable to store it at a cool temperature between 15 to 30 degrees Celsius.

Appearance and packaging

Appearance

White oval tablet

Package unit

4 tablets/PTP[(4 tablets/PTP packaging (AluAlu)x1)]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.